Jakoby WB, Ziegler DMThe enzymes of detoxication. Journal of Biological Chemistry1990; 265: 20715-20718.
2.
Dayer P., Desmeules J., Leeman T., Striberni R.Bioactivation of the narcotic drug codeine in human liver is mediated by the polymorphic monooxygenase catalysing debrisoquine 4-hydroxylation (cytochrome P-450 db1/buf1). Biochemical And Biophysical Research Communications1988; 152: 411-416.
3.
Meisheri KD, Johnson GA, Puddington L.Enzymatic and non-enzymatic sulfation mechanisms in the biological actions of minoxidil. Biochemical Pharmacology1993 ; 45: 271-279.
4.
Miller JARecent studies on the metabolic-activation of chemical carcinogens . Cancer Research1994; 54: S1879-S1881.
5.
Falany CNMolecular enzymology of human liver cytosolic sulfotransferases. Trends in Pharmacological Science1991; 12: 255-259.
6.
Mulder GJ, Jakoby WBSulfation. In Conjugation Reactions in Drug Metabolism . Mulder GJ (ed) pp. 107-161Taylor and Francis , London, 1990.
7.
Weinshilboum R., Otterness D.Sulfotransferase enzymes. In Conjugation-Decongjugation Reactions in Drug Metabolism and Toxicity. Kauffman FC (ed) pp. 45-78Springer-Verlag, Berlin, 1994.
8.
Lyle S., Stanczak J., Ng K., Schwartz NBRat chondrosarcoma ATP sulfurylase and adensosine 5'-phosphosulfate kinase reside on a single bifunctional protein. Biochemistry1994; 33: 5920-5925.
9.
Yamazoe Y., Nagata K., Ozawa S., Kato R.Structural similarity and diversity of sulfotransferases. Chemico-BiologicalInteractions1994; 92: 107-117.
10.
Dooley TP et al. Mapping of the phenol sulfotransferase gene (STP) to human chromosome 16p12.1-p11.2 and to mouse chromosome 7. Genomics1993; 18: 440-443.
11.
Dooley TP et al. Genomic organization and DNA-sequence of the human catecholamine-sulfating phenol sulfotransferase gene (STM). Biochemical And Biophysical Research Communications1994; 205: 1325-1332.
12.
Aksoy IA et al. Thermolabile phenol sulfotransferase gene (STM) - localization to human-chromosome 16p11.2. Genomics1994 ; 23: 275-277.
13.
Otterness DM , Mohrenweiser HW, Brandriff BF, Weinshilboum RMDehydroepiandrosterone sulfotransferase gene (STD): Localization to human chromosome band 19q13.3 . Cytogenetics and Cell Genetics1995; 70: 45-47.
14.
Her C. et al. Human estrogen sulfotransferase gene (STE): cloning, structure, and chromosomal localization. Genomics1995 ; 29: 16-23.
15.
Jarvela IE et al. YAC and cosmid contigs spanning the Batten disease (CLN3) region at 16p12.1-p11.2. Genomics1995; 29: 478-489.
16.
Her CT, Raftogianis R., Weinshilboum R.Human sulfotransferase pharmacogenetics - STP2 gene, structural characterization and chromosomal localization. [Abstract] Clinical Pharmacology & Therapeutics1996; 59: 216.
17.
Chiba H. et al. The 3'-terminal exon of the family of steroid and phenol sulfotransferase genes is spliced at the N-terminal glycine of the universally conserved GXXGXXK motif that forms the sulfonate donor binding site. Proceedings of the National Academy of Sciences USA1995; 92: 8176-8179.
18.
Komatsu K., Driscoll WJ, Koh YC, Strott CAA P-loop related motif (GXXGXXK) highly conserved in sulfotransferases is required for binding the activated sulfate donor. Biochemical And Biophysical Research Communications1994; 204: 1178-1185.
19.
Mizuma T., Komori M., Ueno M., Horikoshi I.Sulphate conjugation enhances reversible binding of drug to human serum albumin . Journal of Pharmacy and Pharmacology1991 ; 43: 446-448.
20.
Mulder GJSulfation in vivo and in isolated intact cell preparations. In Sulfation of Drugs and Other Compounds. Mulder GJ (ed) pp. 131-185CRC Press, Boca Raton , 1981.
21.
Kauffman FC , Whittaker M., Anundi I., Thurman RGFutile cycling of a sulfate conjugate by isolated hepatocytes. Molecular Pharmacology1991; 39: 414-420.
22.
Pesola GR, Walle T.Stereoselective sulfate conjugation of isoproterenol in humans: Comparison of hepatic, intestinal and platelet activity. Chirality1993; 5: 602-609.
23.
Heroux JA, Falany CN, Roth JAImmunological characterization of human phenol sulfotransferase. Molecular Pharmacology1989; 36: 29-33.
24.
Sundaram RS et al. Human intestinal phenol sulfotransferase: Assay conditions, activity levels and partial purification of the thermolabile form. Drug Metabolism And Disposition1989 ; 17: 255-264.
25.
Pacifici GM , De Santi C., Mussi A., Ageletti CAInterindividual variability in the rate of salbutamol sulphation in the human lung. European Journal of Clinical Pharmacology1996; 49: 299-303.
26.
Ozawa S. et al. Primary structures and properties of two related forms of aryl sulfotransferases in human liver. Pharmacogenetics1995; 5: S135-S140.
27.
Surh YJ, Tannenbaum SRSulfotransferase-mediated activation of 7,8,9,10-tetrahydro-7-o1,7,8-dihydrodiol, and 7,8,9,10-tetraol derivatives of benzo[a]pyrene. Chemical Research in Toxicology1995; 8: 693-698.
28.
Hobkirk R.Steroid sulfation-current concepts. Trends in Endocrinology and Metabolism1993; 4: 69-74.
29.
Visser TJRole of sulfation in thyroid hormone metabolism. Chemico-BiologicalInteractions1994; 92: 293-303.
30.
Barker EV, Hume R., Hallas A., Coughtrie Mwh.Dehydroepiandrosterone sulfotransferase in the developing human fetus—quantitative biochemical and immunological characterization of the hepatic, renal, and adrenal enzymes. Endocrinology1994; 134: 982-989.
31.
Kuss E.The fetoplacental unit of primates. Experimental And Clinical Endocrinology1994; 102: 135-165.
32.
Young WF, Laws ER, Sharbrough FW, Weinshilboum RMHuman phenol sulfotransferase: Correlation of brain and platelet activities . Journal of Neurochemistry1985; 44: 1131-1137.
33.
Renskers KJ, Feor KD, Roth JASulfation of dopamine and other biogenic amines by human brain phenol sulfotransferase . Journal of Neurochemistry1980; 34: 1362-1368.
34.
Tyce GM et al. Human liver and conjugation of catecholamines. Journal of Laboratory and Clinical Medicine1987; 109: 532-537.
35.
Clarke CL, Adams JB, Wren BGInduction of estrogen sulfotransferase in the human endometrium by progesterone in organ culture. Journal of Clinical Endocrinology AndMetabolism1982; 55: 70-75.
36.
Robel P., Baulieu E. Neurosteroids: Biosynthesis and function. Trends in Endocrinology and Metabolism1994; 5: 1-8.
37.
Flood JF, Morley JE, Roberts E.Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it. Proceedings of the National Academy of Science USA1989; 89: 1567-1571.
38.
Falany CN, Kerl EASulfation of minoxidil by human liver phenol sulfotransferase. Biochemical Pharmacology1990; 40: 1027-1032.
39.
Kudlacek PE , Clemens DL, Anderson RJCharacterization of recombinant human liver thermolabile phenol sulfotransferase with minoxidil as the substrate. Biochemical And Biophysical Research Communications1995; 210: 363-369.
40.
Buhl AE et al. Minoxidil sulfotransferase activity influences the efficacy of Rogaine® topical solutions (TS)-enzyme studies using scalp and platelets . [Abstract] Journal of Investigative Dermatology1994; 102: 534.
41.
Dooley TP et al. Localization of minoxidil sulfotransferase in rat liver and the outer root sheath of anagen pelage and vibrissa follicles. Journal of Investigative Dermatology1991; 96: 65-70.
42.
Baker CA, Uno H., Johnson GAMinoxidil sulfation in the hair follicle. Skin Pharmacology1994; 7: 335-339.
43.
Garay RP et al. CRE 10904 [2-(-p-fluorophenoxy), 1-(o-hydroxyphenyl)-ethane]: A new diuretic and antihypertensive drug acting by in vivo sulfation. Journal of Pharmacology and Experimental Therapeutics1990 ; 255: 415-422.
44.
Garay RP et al. Evidence for (+)-cicletanine sulfate as an active natriuretic metabolite of cicletanine in the rat. EuropeanJournal of Pharmacology1995; 274: 175-180.
45.
Miller JASulfonation in chemical carcinogenesis-history and present status. Chemico-BiologicalInteractions1994; 92: 329-341.
46.
Boberg EW et al. Strong evidence from studies with brachymorphic mice and pentachlorophenol that 1'-sulfooxysafrole is the major ultimate electrophilic and carcinogenic metabolite of 1'hydroxysafrole in mouse liver. Cancer Research1983; 43: 5163-5173.
47.
Sugahara K. , Schwartz NBDefect in 3'phosphoadenosine 5'-phosphosulfate formation in brachymorphic mice. Proceedings of the National Academy of Sciences USA 1979; 76: 6615-6618.
48.
Meerman Jhn et al. Sulfation of carcinogenic aromatic hydroxylamines and hydroxamic acids by rat and human sulfotransferases - substrate-specificity, developmental aspects and sex-differences. Chemico-BiologicalInteractions1994; 92: 321- 328.
49.
Nagata K. et al. Isolation and expression of a cDNA encoding a male-specific rat sulfotransferase that catalyzes activation of N-hydroxy-2-acetylaminofluorene . Journal Of Biological Chemistry1993; 268: 24720-24725.
50.
Gilissen Rahj et al. Sulfation of aromatic hydroxamic acids and hydroxylamines by multiple forms of human liver sulfotransferases. Carcinogenesis1994; 15: 39-45.
51.
Chou H-C.,Lang NP , Kadlubar FFMetabolic activation of N-hydroxy arylamines and N-hydroxy heterocyclic amines by human sulfotransferase(s). Cancer Research1995; 55: 525-529.
52.
Ozawa S. et al. Activation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-β]pyridine by cDNAexpressed human and rat arylsulfotransferases. Japanese Journal of Cancer Research1994; 85: 1220-1228.
53.
Glatt H. et al. Activation of benzylic alcohols to mutagens by rat and human sulfotransferases expressed in Escherichia coli. European Journal Of Pharmacology1995; 293: 173-181.
54.
Glatt H. et al. Salmonella strains and mammalian cells genetically engineered for expression of sulfotransferases. Toxicology Letters1995; 82-3: 829-834.
55.
Jones AL et al. Human platelet phenolsulfotransferases — cDNA cloning, stable expression in V79 cells and identification of a novel allelic variant of the phenol-sulfating form. Biochemical And Biophysical Research Communications1995; 208: 855-862.
56.
Forbes KJ et al. Human fetal adrenal hydroxysteroid sulphotransferase: cDNA cloning, stable expression in V79 cells and functional characterisation of the expressed enzyme. Molecular And Cellular Endocrinology1995; 112: 53-60.
57.
Jones AL et al. Reduced platelet phenolsulphotransferase activity towards dopamine and 5-hydroxytryptamine in migraine. European Journal Of Clinical Pharmacology1995; 49: 109-114.
58.
Weinshilboum R., Aksoy I.Sulfation pharmacogenetics in humans. Chemico-BiologicalInteractions1994; 92: 233-246.
59.
Reveley AM, Bonham Carter SM, Reveley MA, Sandler M. A genetic study of platelet phenolsulphotransferase activity in normal and schizophrenic twins. Journal ofPsychiatric Research1982; 17: 303-307.
60.
Reiter C., Weinshilboum R.Platelet phenol sulfotransferase activity: Correlation with sulfate conjugation of acetaminophen. Clinical Pharmacology and Therapeutics1982; 32: 612-621.
61.
Aksoy IA, Sochorová V., Weinshilboum RMHuman liver dehydroepiandrosterone sulfotransferase-nature and extent of individual variation. Clinical Pharmacology and Therapeutics1993; 54: 498-506.
